.. Medico-economic-study-design, 17 3.1. Cost estimation of the program 17 3.2. Cost estimation of drug-related hospitalizations, .

L. Osterberg and T. Blaschke, Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, pp.487-97, 2005.
DOI : 10.1056/NEJMra050100

J. Karnon, A. Mcintosh, J. Dean, P. Bath, A. Hutchinson et al., Modelling the expected net benefits of interventions to reduce the burden of medication errors, Journal of Health Services Research & Policy, vol.13, issue.2, pp.85-91, 2008.
DOI : 10.1258/jhsrp.2007.007011

S. Léger, B. Allenet, O. Pichot, G. Figari, J. Calop et al., Impact of an education program on patient behaviour favoring prevention of drug-related adverse events: a pilot study in patients receiving oral anticoagulants for thromboembolic venous disease], J Mal Vasc, 2004.

G. Pernod, J. Labarère, J. Yver, B. Satger, B. Allenet et al., EDUC???AVK: Reduction of Oral Anticoagulant-related Adverse Events After Patient Education: A Prospective Multicenter Open Randomized Study, Journal of General Internal Medicine, vol.40, issue.9, pp.1441-1447, 2008.
DOI : 10.1007/s11606-008-0690-1

URL : https://hal.archives-ouvertes.fr/hal-00291806

M. Chisholm-burns, K. Lee, J. Spivey, C. Slack, M. Herrier et al., US pharmacists' effect as team members on patient care: systematic review and meta-analyses, 2010.

P. Bedouch, M. Roustit, S. Quetant, C. Chapuis, M. Baudrant-boga et al., Development of a pharmacist collaborative care program for pulmonary arterial hypertension, International Journal of Clinical Pharmacy, vol.28, issue.2, pp.898-901, 2011.
DOI : 10.1007/s11096-011-9579-x

URL : https://hal.archives-ouvertes.fr/inserm-00696289

H. Autorité and D. Santé, Evaluation & Recommandation > Évaluation Médico-économique - Portail -Évaluation Médico-économique [Internet]. [cited 2015 Feb 1] Available from

J. Lundkvist and B. Jönsson, Pharmacoeconomics of adverse drug reactions, Fundamental and Clinical Pharmacology, vol.54, issue.3, pp.275-80, 2004.
DOI : 10.1001/archinte.157.18.2089

H. Gyllensten, C. Rehnberg, A. Jönsson, M. Petzold, A. Carlsten et al., Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey, BMJ Open, vol.3, issue.6, 2013.
DOI : 10.1136/bmjopen-2013-002574

W. Katon, J. Russo, E. Lin, J. Schmittdiel, P. Ciechanowski et al., Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial, Arch Gen Psychiatry, vol.69, issue.5, pp.506-520, 2012.

M. Boyd, W. J. Barber, N. Mehta, R. Chuter, A. Avery et al., Protocol for the New Medicine Service Study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in England, Trials, vol.14, issue.1, p.411, 2013.
DOI : 10.1016/S0140-6736(02)08350-2

M. Angalakuditi, E. Edgell, A. Beardsworth, E. Buysman, and T. Bancroft, Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States, Journal of Medical Economics, vol.13, issue.3, pp.393-402, 2010.
DOI : 10.3111/13696998.2010.496694

N. Ehlken, C. Verduyn, H. Tiede, G. Staehler, G. Karger et al., Economic Evaluation of Exercise Training in Patients with Pulmonary Hypertension, Lung, vol.26, issue.984???988, pp.359-66, 2014.
DOI : 10.1007/s00408-014-9558-9

G. Lagger, Z. Pataky, and A. Golay, Efficacy of therapeutic patient education in chronic diseases and obesity, Patient Education and Counseling, vol.79, issue.3, pp.283-289, 2010.
DOI : 10.1016/j.pec.2010.03.015

. Document, Analyse critique de la littérature document_de_travail ._analyse_critique_de_la_litterature.pdf [Internet], 2015.

M. Référentiel-de-coûts, Available from: http://www.scansante.fr, Stats ATIH [Internet], pp.3-9, 2011.

J. Donadieu and O. Fenneteau, Neutropénies constitutionnelles et acquises. EMC -Hématologie, 2005.

E. Andrès, T. Weitten, L. Federici, M. Mecili, E. Ciobanu et al., Neutropénie de l'adulte et du sujet âgé. Médecine Thérapeutique, pp.314-335, 2008.

S. Reed, Y. Li, S. Ellis, J. Isitt, S. Cheng et al., Associations Between Hemoglobin Level, Resource Use, and Medical Costs in Patients With Heart Failure: Findings From HF-ACTION, Journal of Cardiac Failure, vol.18, issue.10, pp.784-91, 2012.
DOI : 10.1016/j.cardfail.2012.08.359

M. Sokol, K. Mcguigan, R. Verbrugge, and R. Epstein, Impact of medication adherence on hospitalization risk and healthcare cost. Med Care, pp.521-551, 2005.

A. Go, G. Chertow, D. Fan, C. Mcculloch, and C. Hsu, Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization, New England Journal of Medicine, vol.351, issue.13, pp.1296-305, 2004.
DOI : 10.1056/NEJMoa041031

D. Regier, R. Sunderji, L. Lynd, K. Gin, and C. Marra, Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy, Canadian Medical Association Journal, vol.174, issue.13, pp.1847-52, 2006.
DOI : 10.1503/cmaj.051104

R. Krasuski, S. Hart, B. Smith, A. Wang, J. Harrison et al., Association of anemia and long-term survival in patients with pulmonary hypertension, International Journal of Cardiology, vol.150, issue.3, pp.291-296, 2011.
DOI : 10.1016/j.ijcard.2010.04.038

L. Mielniczuk, G. Chandy, D. Stewart, V. Contreras-dominguez, H. Haddad et al., Worsening renal function and prognosis in pulmonary hypertension patients hospitalized for right heart failure. Congest Heart Fail Greenwich Conn, pp.151-158, 2012.